CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 22 filers reported holding CLEVELAND BIOLABS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 400,080 | $2,188,000 | 0.31% |
| Sequoia Financial Advisors, LLC | 12,588 | $69,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 48,725 | $267,000 | 0.00% |
| Archer Investment Corp | 300 | $1,641,000 | 0.00% |
| Renaissance Technologies | 98,051 | $536,000 | 0.00% |
| VANGUARD GROUP INC | 97,535 | $533,000 | 0.00% |
| FMR LLC | 100 | $1,000 | 0.00% |
| US BANCORP \DE\ | 1,000 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 151 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 51 | $0 | 0.00% |